Earnings

Should You Invest in Northwest Biotherapeutics (NWBO)? A Look at the Insider Trends

Recent insider trends for Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) have caught the attention of investors. Insider activity is often a strong indicator of future performance in a stock, and if the data on NWBO is anything to go by, investors should pay attention.

Institutions own 00.01% of Northwest Biotherapeutics, Inc. (NWBO)’s shares. The total value of these holdings, in millions, is $0. Among active positions in the latest quarter, 0 holders increased their positions by a total of 0 shares, 2 holders decreased the positions by a total of 95717 shares, and 2 holders held their positions. This works out to a net decrease in ownership of 95717 shares, and suggests that institutions are feeling bearish about the stock.

Among new and sold out positions, 0 holders initiated new positions by a total of 0 shares and 2 holders exited their positions by a total of 95717 shares. This nets out to a decrease of 95717 shares and is another bearish sign for NWBO.

Comparing the number of shares sold short over time is a method analysts often use to get a reading on investor sentiment. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO)’s short interest is 3.69 million shares, or % of the float. This represents an increase of 8% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks.



Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that NWBO is a sell, which implies that NWBO is expected to underperform the market based on prior trading patterns.

Conclusion

Institutional ownership trends suggest that the stock is expensive and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) is overvalued.

Previous ArticleNext Article

Related Post

Which of 2 stocks would appeal to long-term invest... The shares of Boardwalk Pipeline Partners, LP have decreased by more than -13.17% this year alone. The shares recently went up by 2.47% or $0.27 and n...
Which of these 2 stocks can turn out to be absolut... The shares of Nutanix, Inc. have increased by more than 42.46% this year alone. The shares recently went up by 3.37% or $1.64 and now trades at $50.26...
Choosing Between Hot Stocks: Iconix Brand Group, I... The shares of Iconix Brand Group, Inc. have decreased by more than -48.06% this year alone. The shares recently went down by -3.67% or -$0.03 and now ...
Macy’s, Inc. (M) vs. Kohl’s Corporatio... Macy's, Inc. (NYSE:M) shares are down more than -47.08% this year and recently increased 1.01% or $0.19 to settle at $18.95. Kohl's Corporation (NYSE:...
Comparing Top Moving Stocks Stellar Biotechnologie... The shares of Stellar Biotechnologies, Inc. have decreased by more than -63.14% this year alone. The shares recently went up by 26.67% or $0.44 and no...